Transverse myelitis in a patient with Behcet's disease: favorable outcome with a combination of interferon-alpha.
We report here on a 24-year-old patient with Behcet's disease who had been diagnosed with acute transverse myelitis. He was successfully treated with a combination regimen of a steroids, cyclophosphamide, and interferon-alpha. The treatment strategy with specific emphasis on interferon-alpha is discussed in the light of the pertinent literature.
Calgüneri
Meral
M
Department of Rheumatology, Hacettepe University Medical School, Ilkadim mah Namdar sok 17/16 Dikmen, Ankara, Turkey.
Onat
Ahmet Mesut
AM
Oztürk
M Akif
MA
Ozçakar
Levent
L
Ureten
Kemal
K
Akdogan
Ali
A
Ertenli
Ihsan
I
Kiraz
Sedat
S
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D001528:Behcet Syndrome / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D004333:Drug Administration Routes; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage; D006074:Gout Suppressants / Q000008:administration & dosage; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D016898:Interferon-alpha / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008297:Male; D009188:Myelitis, Transverse / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D013116:Spinal Cord / Q000473:pathology; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D006074:Gout Suppressants; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D016898:Interferon-alpha